Protagonist Therapeutics
PTGX
#2239
Rank
S$10.70 B
Marketcap
S$163.97
Share price
2.00%
Change (1 day)
49.34%
Change (1 year)

Earnings for Protagonist Therapeutics (PTGX)

Earnings in 2026 (TTM): S$0.10 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current earnings are S$0.28 Billion. In 2025 the company made an earning of -S$0.17 Billion a decrease over its 2024 earnings that were of S$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protagonist Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.10 B-165.81%
2025 -S$0.17 Billion-146.28%
2024 S$0.36 B-453.88%
2023 -S$0.11 Billion-38.02%
2022 -S$0.17 Billion1.47%
2021 -S$0.17 Billion93.62%
2020 -S$83.62 Million-16.74%
2019 -S$0.11 Billion96.06%
2018 -S$51.23 Million7.48%
2017 -S$47.66 Million-0.59%
2016 -S$47.94 Million150.22%
2015 -S$19.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.21 Billion-285.13%๐Ÿ‡บ๐Ÿ‡ธ USA